Population
416 patients with adrenocortical carcinoma diagnosed between 1986 and 2007 from the German ACC Registry…
Design
Cohort
Follow-up
mean 36 months
Authors
Loading...
Current ACC staging may not differentiate stage II from III survival; supports revised systems like ENSAT with prospective validation.
The 2004 UICC staging classification for adrenocortical carcinoma has significant limitations in prognostic accuracy, prompting the proposal of a revised classification (ENSAT).
Faßnacht et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: